5Ozdemir O,Emn S,Karakoca Y,et al.Fibrinolytic system plasma and pleural fluid in malignant pleural mesothelioma. Thrombosis Research . 1996
6Casslen B,Bossmar T,Lecander I,et al.Plasminogen activators and plasmingogen activator inhibitors in blood and tumor fluids of patients with ovarian cancer. European Journal of Cancer . 1994
7Toschi V,Rocchini GM,Motta A,et al.The hyperfibrinolytic state of liver cirrhosis: Possible pathogenetic role of ascites. Biomedicine and Pharmacotherapy . 1993
8Ascoli V,Scalzo CC,Taccogna S,et al.The diagnostic value of thrombomodulin immunolocalization in serous effusion. Archives of Pathology and Laboratory Medicine . 1995
4Sharif-Kashani B,Bikdeli B,Moradi A,et al.Coexisting venous thromboembolism in patients with tuberculosis[J].Thrombosis Research,2010,125(5):478-480.
5White NW.Venous thrombosis and rifampicin[J].Lancet,1989,2(8660):434-435.
6Komazaki Y,Sakakibara Y,Sakashita H,et al.Pulmonary thromboembolism with Pulmonary tuberculosis[J].Kekkaku,2011,86(7):717-722.
7Smeeth L,Cook C,Thomas S,et al.Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting[J].Lancet,2006,367(9516):1075-1079.
8Turken O,Kunter E,Sezer M,et al.Hemostatic changes in active pulmonary tuberculosis[J].Int J Tuberc Lung Dis,2002,6(10):927-932.
